Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient [0.03%]
一例难治性Sweet综合征患者使用阿达木单抗治疗成功案例——并发骨髓增生异常综合症
Liya Ma,Yaojia Shen,Jie Chang et al.
Liya Ma et al.
We report a 69-year-old man diagnosed as myelodysplastic syndrome and administrated with azacitidine and selinexor treatment. Then he was revealed high fever and multiple tender erythematous papules involving his mouth, back, upper and lowe...
Hemophagocytic Lymphohistiocytosis as First Manifestation of Dual B-Cell Neoplasms: A Case Report of Co-Existing Multiple Myeloma and B-Cell Lymphoma [0.03%]
原发性血细胞吞噬淋巴组织细胞增生症作为双生B淋巴细胞肿瘤首发表现的一例报告：多发性骨髓瘤合并B细胞淋巴瘤一例
Carla Romagnoli,Alexandra Lyubimova,Leily Santos-Carrion et al.
Carla Romagnoli et al.
Hemophagocytic lymphohistiocytosis (HLH) is an immune disorder causing excessive inflammation and tissue damage. Lymphoma, especially T-cell lymphoma, is the most common cause of HLH, while Multiple Myeloma (MM) is rarely associated. We pre...
Edwin U Suárez,Teresa Arquero-Portero,Pilar Llamas-Sillero
Edwin U Suárez
Cytogenomic Abnormalities in Children With Acute Lymphoblastic Leukemia From Western Mexico: A Single-Center Fluorescence In Situ Hybridization-Based Study [0.03%]
墨西哥西部儿童急性淋巴细胞白血病患者的染色体基因组异常：一项以荧光原位杂交为基础的单中心研究
Rosa María González Arreola,María Teresa Magaña Torres,Ma Guadalupe Domínguez Quezada et al.
Rosa María González Arreola et al.
Introduction: In Mexico, the 5-year overall survival (OS) rate for pediatric acute lymphoblastic leukemia (ALL) ranges from 45% to 85%, markedly lower than the ∼90% reported in high-income countries, where cytogenomic te...
Innate Immune Cell Infiltration Induced by Polatuzumab Vedotin Contributes to the Antitumor Effect in Mouse Models [0.03%]
靶向CD79b的抗体药物偶联物Polatuzumab vedotin通过诱导先天免疫细胞浸润发挥抗肿瘤作用
Mayu Tomita,Natsumi Kawasaki,Keigo Yorozu et al.
Mayu Tomita et al.
Introduction: Polatuzumab vedotin (Pola) is an antibody-drug conjugate approved for the treatment of diffuse large B-cell lymphoma (DLBCL). Several reports suggest that the tumor microenvironment influences the outcome of...
Refractory Periorbital Necrobiotic Xanthogranuloma Treated With Plasma Cell-Directed Therapy [0.03%]
抗浆细胞治疗难治性眼眶区泡沫细胞肉芽肿型脂膜炎有效
Aaron Trando,Ah-Reum Jeong,Aaron M Goodman
Aaron Trando
Immunophenotypically Defined Mixed-Phenotype Acute Leukemias: A Clinicopathologic Analysis of 52 Cases [0.03%]
免疫表型定义的混合表型急性白血病：52例临床病理分析
Bo Zhang,Olga K Weinberg,Weina Chen et al.
Bo Zhang et al.
Background: Immunophenotypically defined mixed-phenotype acute leukemias (MPAL) are rare and remain a diagnostic and therapeutic dilemma. We aim to explore the clinicopathologic characteristics and oncological outcomes of...
Whole Genome and Single-Cell RNA Sequencing Reveals Clonal Evolution and Heterogeneity of Secondary Plasma Cell Leukemia: A Case Report [0.03%]
全基因组和单细胞RNA测序揭示二次浆细胞白血病的克隆演化及异质性：病例报告
Tomotaka Suzuki,Rui Yokomori,Takaomi Sanda et al.
Tomotaka Suzuki et al.
Secondary plasma cell leukemia (sPCL) is a rare, aggressive manifestation of multiple myeloma (MM). We report a 75-year-old Japanese man with anemia as the chief complaint and IgG-λ MM that rapidly progressed to sPCL. Whole genome sequenci...
Erratum to Machine Learning-Based Detection of HbS and HbC Carriers in the UK General Population [0.03%]
基于机器学习的英国人群中HbS和HbC携带者检测的勘误表
[This corrects the article DOI: 10.1002/jha2.70170.]. © 2026 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Lt...
Published Erratum
EJHaem. 2026 Jan 8;7(1):e70209. DOI:10.1002/jha2.70209 2026